60 Degrees Pharmaceuticals, Inc. SEC filings SXTP
60 Degrees Pharmaceuticals, Inc. has 222 filings in SEC EDGAR's recent list, going back to Oct 18, 2022. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 6, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 4, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 20, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Other events
|
Jul 9, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Other events
|
Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Officer or director change
|
May 18, 2026 | May 13, 2026 |
| 8-K |
Current report
Other events
|
Mar 20, 2026 | Mar 20, 2026 |
| 8-K |
Current report
Other events
|
Mar 13, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Other events
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Other events
|
Feb 12, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 23, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jan 21, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 10, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Sep 5, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 18, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Other events
|
Apr 9, 2025 | Apr 4, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 6, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 30, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Other events
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Other events
|
Jan 8, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Oct 8, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 6, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Other events
|
Aug 28, 2024 | Aug 26, 2024 |
| 8-K |
Current report
Other events
|
Aug 14, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Other events
|
Jul 26, 2024 | Jul 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 16, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Other events
|
Jun 12, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Other events
|
May 2, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Other events
|
Mar 15, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Listing notice
|
Feb 28, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 20, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 2, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Other events
|
Jan 22, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Other events
|
Jan 16, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 3, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Oct 12, 2023 | Oct 6, 2023 |
| 8-K |
Current report
Other events
|
Sep 18, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 17, 2023 | Jul 12, 2023 |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTP (Nasdaq), SXTPW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Washington, DC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1946563
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.